Crossmark

Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1186/s13195-018-0407-6

Published Online: 2018-08-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Zhang, Hua

Therriault, Joseph

Kang, Min Su

Ng, Kok Pin

Pascoal, Tharick A.

Rosa-Neto, Pedro

Gauthier, Serge
Funding

Funding for this research was provided by:

Weston Brain Institute, Canadian Institutes of Health Research (CIHR) (MOP-11-51-31)

the Alzheimer's Association (NIRG-12- 92090, NIRP-12-259245)

Fonds de Recherche du Québec - Santé (FRQS; Chercheur Boursier)

Clinical key specialist fund, the Department of Neurology, the First Affiliated Hospital of Chongqing Medical University
License Information

Text and Data Mining valid from 2018-08-16
More Information

Article History

Received: 20 March 2018

Accepted: 12 July 2018

First Online: 16 August 2018

Ethics approval and consent to participate

: The ADNI study was approved by the Institutional Review Boards of all the participating institutions. Informed written consent was obtained from all subjects at each center.

: All authors approved the final manuscript for submission and gave consent for publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.